Inactive Instrument
Ark Therapeutics Group plc Share Price London S.E.
Stocks
GB0034251727
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Market Cap | 5.29M 7.08M 6.21M 5.73M 10.04M 678M 10.24M 68.88M 26.76M 332M 26.57M 25.99M 1.15B | P/E 2024 |
1.51x | P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | -9.39M -12.55M -11.01M -10.16M -17.8M -1.2B -18.16M -122M -47.48M -588M -47.14M -46.11M -2.04B | EV / Sales 2024 |
-0.1x | EV / Sales 2025 | -0.56x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 01/07/16 | Premier Veterinary : Appointment of Broker | PU |
| 28/06/16 | Premier Veterinary : Further Major Agreement Signed in the US | PU |
| 21/06/16 | Premier Veterinary : Director's Dealings | PU |
| 21/06/16 | Premier Veterinary : Block Listing Application and Directors' Dealings | PU |
| 14/06/16 | Premier Veterinary : Director's Dealings | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Dominic Tonner
CEO | Chief Executive Officer | 69 | 26/02/2015 |
Andrew Paull
DFI | Director of Finance/CFO | 52 | 29/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Graham Dick
CHM | Chairman | 75 | 28/02/2018 |
Dominic Tonner
BRD | Director/Board Member | 69 | 26/02/2015 |
Rajan Uppal
BRD | Director/Board Member | 63 | 26/02/2015 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.53M 22.09M 19.38M 17.89M 31.33M 2.12B 31.96M 215M 83.55M 1.04B 82.96M 81.14M 3.59B | 16.85M 22.52M 19.75M 18.23M 31.94M 2.16B 32.57M 219M 85.17M 1.06B 84.56M 82.7M 3.66B |
| Net income | 3.9M 5.22M 4.58M 4.23M 7.4M 500M 7.55M 50.8M 19.74M 245M 19.6M 19.17M 849M | 3.64M 4.87M 4.27M 3.94M 6.91M 466M 7.05M 47.41M 18.42M 228M 18.29M 17.89M 792M |
| Net Debt | -6.94M -9.27M -8.13M -7.51M -13.15M -888M -13.42M -90.28M -35.08M -435M -34.83M -34.07M -1.51B | -14.69M -19.63M -17.22M -15.89M -27.84M -1.88B -28.4M -191M -74.24M -920M -73.71M -72.1M -3.19B |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















